INFIGRATINIB ACETATE
UNII 03D0789NYP

Substance Identification & Data

This profile provides standardized clinical and technical data for Infigratinib Acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 03D0789NYP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1310746-17-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

03D0789NYP

CAS Registry Number

1310746-17-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

INFIGRATINIB ACETATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C26H31Cl2N7O3.C2H4O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XHCQHOGMMJKLRU-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C217982

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

91618031

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(=O)(C)O.N(C(=O)N(C)c1ncnc(Nc2ccc(N3CCN(CC)CC3)cc2)c1)c4c(Cl)c(OC)cc(OC)c4Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Infigratinib Acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.